alexa Abstract | A Review Of The Development Of Biostatistical Design And Analysis Techniques For Assessing In Vivo Bioequivalence : Part One

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


Bioequivalence studies are performed to demonstrate that two pharmaceutically equivalent products are equal in rate and extent of absorption in vivo. Following on from developments in the pharmaceutical industry and government mandates in the 1970's and 1980's and since the early 1990's, average bioequivalence has served as the international standard for demonstrating that two formulations of drug product will provide the same therapeutic benefit and safety profile when used in the marketplace. Population (PBE) and Individual (IBE) bioequivalence has been the subject of Intense international debate since methods for their assessment were proposed in the late 1980's. Guidance has been proposed by the Food and Drug Administration of the United States government for the implementation of these techniques in the pioneer and generic pharmaceutical industries. Implementation of these techniques may follow a data collection period to evaluate the operating characteristics, efficiency, and metrics involved in PBE and IBE assessment. The history of bioequivalence will be described, and various techniques and study designs for in vivo bioequivalence assessment will be provided. Part One of this series will develop the ideas behind bioequivalence and discuss development of average bioequivalence. Part Two of this series will describe the implementation of average bioequivalence in industry and the development of population and individual bioequivalence.

To read the full article Peer-reviewed Article PDF image

Author(s): Scoot D Patterson

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version